GSK Acquires Syndivia's Prostate Cancer ADC GSK has acquired the rights to Syndivia's preclinical antibody drug conjugate (ADC) for prostate cancer treatment. Despite having its own…
Weekly Injectable Treatment for Parkinson's Disease Parkinson's disease, the second most common neurodegenerative disorder after Alzheimer…
Canada’s Lululemon Partners With National Football League Canada’s Lululemon Athletica (LULU) is partnering with the National Football Lea…
Racial Disparities in Victim Compensation Families of Black homicide victims are more likely to file victim compensation claims but face h…
Meet the AI Disruptors 60 There are only a few times in life when you get to live through a revolution, such as the internet, mobile, and …
Acorns Invests In Financial Wellness For Overlooked Audience The "Show Your Potential" campaign features real-life, relatable stories.…
TechCrunch Disrupt 2025: Livestream and Schedule TechCrunch Disrupt 2025 is underway, and for those unable to attend in person, a livestre…
Deandre Ayton Claims Lakers Superstars Troll Him for Motivation Deandre Ayton had a standout game against the Sacramento Kings, scoring 22…
ACCC Sues Microsoft Over Alleged Misleading Subscription Practices The Australian Competition and Consumer Commission (ACCC) has filed a F…
Announcements: week of Oct. 27, 2025 The Rider Newspaper presents the following events: Monday Tabling: Christians at RGV w…
Meta and Engie Sign 600MW Solar PV PPA in Texas Engie has signed additional power purchase agreements (PPAs) with Meta, expanding their pa…